Relationship between serum uric acid, nocturnal hypertension and risk for preeclampsia in high-risk pregnancies.
Journal
Journal of human hypertension
ISSN: 1476-5527
Titre abrégé: J Hum Hypertens
Pays: England
ID NLM: 8811625
Informations de publication
Date de publication:
23 Jul 2024
23 Jul 2024
Historique:
received:
22
04
2024
accepted:
17
07
2024
revised:
10
07
2024
medline:
24
7
2024
pubmed:
24
7
2024
entrez:
23
7
2024
Statut:
aheadofprint
Résumé
To analyze the possible association between serum uric acid (SUA) and nocturnal hypertension and to evaluate the ability of these variables (alone or in combination) to predict preeclampsia (PE) we conducted a historical cohort study in 532 high-risk pregnancies. Women were divided according to SUA values and nocturnal blood pressure (BP) into four groups: 1- normal SUA and nocturnal normotension; 2- high SUA and nocturnal normotension; 3- normal SUA and nocturnal hypertension and 4- high SUA and nocturnal hypertension. High SUA was defined by the top quartile values and nocturnal hypertension as BP ≥ 120/70 mmHg, using ambulatory blood pressure monitoring (ABPM), during nocturnal rest. Risks for PE were compared using logistic regression. SUA had a weak but significant correlation with daytime systolic ABPM (r = 0.11, p = 0.014), daytime diastolic ABPM (r = 0.13, p = 0.004), nighttime systolic ABPM (r = 0.16, p < 0.001) and nighttime diastolic ABPM (r = 0.18, p < 0.001). Also, all ABPM values were higher in women with high SUA. The absolute risk of PE increased through groups: 6.5%, 13.1%, 31.2%, and 47.9% for groups 1, 2, 3, and 4, respectively, p < 0.001. Compared with Group 1, Group 3 (OR 6.29 95%CI 3.41-11.60), but not Group 2 (OR 2.15 95%CI 0.88-5.24), had statistically significant higher risk for PE. Group 4 (women with both, high SUA and nocturnal hypertension) had the highest risk (OR 13.11 95%CI 6.69-25.70). Risks remained statistically significant after the adjustment for relevant variables. In conclusion, the combination of SUA > 4 mg/dL and nocturnal BP > 120/70 mmHg implies a very high risk to developed PE.
Identifiants
pubmed: 39043990
doi: 10.1038/s41371-024-00939-w
pii: 10.1038/s41371-024-00939-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387:999–1011.
doi: 10.1016/S0140-6736(15)00070-7
pubmed: 26342729
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1–7.
doi: 10.1016/j.ejogrb.2013.05.005
pubmed: 23746796
Veisani Y, Jenabi E, Delpisheh A, Khazaei S. Angiogenic factors and the risk of preeclampsia: a systematic review and meta-analysis. Int J Reprod Biomed. 2019;17:1–10.
doi: 10.18502/ijrm.v17i1.3815
pubmed: 31435580
pmcid: 6652157
Bellos I, Papantoniou N, Pergialiotis V. Serum ceruloplasmin levels in preeclampsia: a meta-analysis. J Matern Neonatal Med. 2018;31:2342–8.
doi: 10.1080/14767058.2017.1340449
Bellos I, Karageorgiou V, Kapnias D, Karamanli K-E, Siristatidis C. The role of interleukins in preeclampsia: a comprehensive review. Am J Reprod Immunol. 2018;80:e13055.
doi: 10.1111/aji.13055
pubmed: 30265415
Tomimatsu T, Mimura K, Endo M, Kumasawa K, Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res. 2017;40:305–10.
doi: 10.1038/hr.2016.152
pubmed: 27829661
Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8–14.
doi: 10.1016/j.ijcard.2015.08.109
pubmed: 26316329
Shankar A, Klein R, Klein BEK, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: a population-based cohort study. J Hum Hypertens. 2006;20:937–45.
doi: 10.1038/sj.jhh.1002095
pubmed: 17024135
Kuwabara M, Niwa K, Nishi Y, Mizuno A, Asano T, Masuda K, et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hiperuricemia and hypertension. Hypertens Res. 2014;37:785–9.
doi: 10.1038/hr.2014.75
pubmed: 24671018
Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:102–10.
doi: 10.1002/acr.20344
Cicero AFG, Salvi P, D’Addato S, Rosticci M, Borghi C. Group for the BHS. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. J Hypertens. 2014;32:57–64.
doi: 10.1097/HJH.0b013e328365b916
pubmed: 24309486
Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008;29:67–72.
doi: 10.1016/j.placenta.2007.11.001
Krakoff LR. Nocturnal blood pressure and cardiovascular risk. Hypertension. 2020;76:316–7.
doi: 10.1161/HYPERTENSIONAHA.120.14409
pubmed: 32639886
Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertens Res. 2012;35:695–701.
doi: 10.1038/hr.2012.26
pubmed: 22378470
Salazar MR, Espeche WG, Leiva Sisnieguez BC, Balbín E, Leiva Sisnieguez CE, Stavile RN, et al. Significance of masked and nocturnal hypertension in normotensive women coursing a high-risk pregnancy. J Hypertens. 2016;34:2248–52.
doi: 10.1097/HJH.0000000000001067
pubmed: 27490952
Salazar MR, Espeche WG, Balbín E, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Stavile RN, et al. Office blood pressure values and the necessity of out-of-office measurements in high-risk pregnancies. J Hypertens. 2019;37:1838–44.
doi: 10.1097/HJH.0000000000002140
pubmed: 31157745
Salazar MR, Espeche WG, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Balbín E, Stavile RN, et al. Nocturnal hypertension in high-risk mid-pregnancies predict the development of preeclampsia/eclampsia. J Hypertens. 2019;37:182–6.
doi: 10.1097/HJH.0000000000001848
pubmed: 30015756
Bello NA, Woolley JJ, Cleary KL, Falzon L, Alpert BS, Oparil S, et al. Accuracy of blood pressure measurement devices in pregnancy: a systematic review of validation studies. Hypertension. 2018;71:326–35.
doi: 10.1161/HYPERTENSIONAHA.117.10295
pubmed: 29229741
The jamovi project (2022). jamovi. (Version 2.3) [Computer Software]. Retrieved from https://www.jamovi.org .
Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326–133.
doi: 10.1097/AOG.0b013e3181c2bde8
pubmed: 19935037
Grassi G, Quarti-Trevano F, Dell’Oro R, Cuspidi C, Mancia G. The PAMELA research project: a 25-year long journey. Panminerva Medica. 2021;63:430–5.
doi: 10.23736/S0031-0808.21.04396-2
pubmed: 33878850
Bellomo G, Venanzi S, Saronio P, Verdura C, Narducci PL. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension. 2011;58:704–8.
doi: 10.1161/HYPERTENSIONAHA.111.177212
pubmed: 21876075
Johnson RJ, Kanbay M, Kang DH, Sánchez-Lozada LG, Feig D. Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension. 2011;58:548–9. https://doi.org/10.1161/HYPERTENSIONAHA.111.178921
doi: 10.1161/HYPERTENSIONAHA.111.178921
pubmed: 21876074
Lyall F, Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: Relationship to clinical outcome. Hypertension. 2013;62:1046–54.
doi: 10.1161/HYPERTENSIONAHA.113.01892
pubmed: 24060885
Saito Y. The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection. J Mol Cell Cardiol. 2021;151:106–12.
doi: 10.1016/j.yjmcc.2020.10.001
pubmed: 33045252
Chen Y, Di X, Xiang G, Liu Y, Pan X, Deng W, et al. sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring (ABPM) for preeclampsia development. Hypertens Res. 2023. https://doi.org/10.1038/s41440-023-01509-2 .
Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22.
doi: 10.1056/NEJMoa1414838
pubmed: 26735990
Lv LJ, Ji WJ, Wu LL, Miao J, Wen JY, Lei Q, et al. Thresholds for ambulatory blood pressure monitoring based on maternal and neonatal outcomes in late pregnancy in a southern Chinese population. J Am Heart Assoc. 2019;8:e012027.
doi: 10.1161/JAHA.119.012027
pubmed: 31267796
pmcid: 6662146
Salazar MR, Espeche WG, March CE, Marillet AG, Balbín E, Dulbecco CA, et al. Optimal uric acid threshold to identify insulin resistance in healthy women. Metab Syndr Relat Disord. 2012;10:39–46.
doi: 10.1089/met.2011.0072
pubmed: 21933003